O'Shaughnessy Asset Management, LLC Lineage Cell Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.84 - $2.68 $728 - $1,061	-396 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$2.26 - $2.86 $325 - $411	-144 Reduced 26.67%	396 $1,000
Q1 2021 May 14, 2021	BUY	$1.77 - $3.1 $954 - $1,670	539 Added 53900.0%	540 $1,000
Q4 2019 Feb 12, 2020	BUY	$0.54 - $1.01 $0 - $1	1 New	1 $0

120

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.